Contact information
Alexander Ooms
MSc
OCTRU Senior Medical Statistician
I am a statistician primarily interested in Bayesian and early phase trials with fun and clever designs
I am a mathematician turned statistician. My primary interest is in early phase trials and adaptive designs, hopefully with a bit of Bayesian somewhere in there.
A lot of my time is spent designing, setting up, monitoring and analysing clinical trials - looking particularly at the efficacy and safety of treatments. I am also part of the CSM Early Phase Team, where we meet to discuss new analysis techniques and recently developing methodologies and how we could potentially implement these in a clinical setting.
I joined Oxford Clinical Trials Research Unit (OCTRU), part of Centre for Statistics in Medicine (CSM) within NDORMS in October 2018 as a medical statistician. Prior to this I completed my MSc in Statistics from The London School of Economics and Political Science in July 2018 where much of my study was focused on adaptive modelling, Bayesian Statistics and machine learning and data mining techniques - the fun bits, basically. I also have a first class Mathematics degree from the University of York.
In my spare time I love playing sport, particularly anything that involves hitting some form of ball, playing my guitar and reading.
Recent publications
-
Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer: protocol summary of the Emerald-Pancreas phase 1/expansion study located at Oxford University Hospital, UK.
Journal article
Teoh S. et al, (2023), Bmj open, 13
-
Optimising Psoriatic Arthritis Therapy with Immunological Methods to Increase Standard Evaluation: The protocol of an open-label multi-centre, parallel-group, two arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis.
Journal article
RICHARDS D., (2023), Bmj open
-
Cost-utility analysis of surgical fixation with Kirschner wire versus casting after fracture of the distal radius : a health economic evaluation of the DRAFFT2 trial.
Journal article
Png ME. et al, (2022), Bone joint j, 104-B, 1225 - 1233
-
A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study.
Journal article
Speich B. et al, (2022), Trials, 23
-
Randomised controlled trial of a behaviour change physiotherapy intervention to increase physical activity following hip and knee replacement: the PEP-TALK trial.
Journal article
Smith TO. et al, (2022), Bmj open, 12